Abstract
Etanercept is an antagonist of tumor necrosis factor alpha that was developed to treat rheumatoid arthritis. In this report we present a patient who developed myasthenia gravis while taking etanercept and had resolution of symptoms after stopping it. This is the first report of this potential side effect and is of additional interest, because etanercept has been proposed as a treatment for myasthenia gravis.
Original language | English |
---|---|
Pages (from-to) | 866-870 |
Number of pages | 5 |
Journal | Muscle and Nerve |
Volume | 39 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2009 |
Keywords
- Acetylcholine receptor antibodies
- Enbrel
- Etanercept
- Myasthenia gravis
- Pathophysiology
ASJC Scopus subject areas
- Physiology
- Clinical Neurology
- Cellular and Molecular Neuroscience
- Physiology (medical)